GTEx Histological Images
Displaying 25 of 25288 results.
| Search Results | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Case ID | Age | Gender | Specimen ID | Tissue Type | Fixative | Autolysis | Pathology Review Comments | Acceptability | Action |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-1426 | Esophagus - mucosa | PAXgene | 1 | 6 pieces; epithelium is partially sloughing, small focus of muscularis (not target); ectatic, thick-walled vessels c/w varices | Acceptable |  |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-1526 | Esophagus - muscularis | PAXgene | 1 | 6 pieces; target musculairs | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-1626 | Liver | PAXgene | 1 | 2 pieces; cirrhosis, chronic inflammation, Mallory's hyaline, bile pigment and hepatocyte degeneration/necrosis | Unacceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-1726 | Omentum | PAXgene | 1 | 2 pieces; lobulated mature fat, clusters of reactive mesothelial cells, mild chronic inflammation | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-1826 | Pancreas | PAXgene | 2 | 2 pieces; 10 and 40% fat and fibrous tissue, scattered chronic inflammatory cells | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-1926 | Gastroesophageal junction | PAXgene | 1 | 6 pieces; target muscularis, few pieces include small portion of fat (up to 10%) | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-2026 | Spleen | PAXgene | 2 | 2 pieces; some congestion | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-2126 | Kidney - cortex | PAXgene | 2 | 6 pieces; glomeruli in all sections, several sclerotic, arteriosclerosis, small portion of medulla | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-2226 | Adrenal glands | PAXgene | 2 | 2 pieces; 1 piece includes 20% attachment of fat | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-2326 | Stomach | PAXgene | 3 | 6 pieces; fill thickness sections, mucosa largely autolyzed | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-2426 | Colon, transverse | PAXgene | 2 | 6 pieces; full thickness sections, mucosa largely autolyzed | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-2526 | Ileum | PAXgene | 2 | 5 pieces; autolyzed mucosa with scattered residual lymphoid aggregates, small focus of muscularis (not target) | Unacceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-2626 | Colon, sigmoid | PAXgene | 1 | 6 pieces; target muscularis | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-2726 | Vagina | PAXgene | 1 | 6 pieces | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-2826 | Brain - cerebellum | PAXgene | 1 | 4 pieces | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-2926 | Brain - cortex | PAXgene | 1 | 4 pieces | Acceptable | |
| GTEX-1HBPM | 61-70 | Female | GTEX-1HBPM-3026 | Pituitary gland | PAXgene | 1 | 1 piece; ~80% adenohypophysis, ~20% neurohypophysis | Acceptable | |
| GTEX-1HBPN | 51-60 | Male | GTEX-1HBPN-0126 | Skin, suprapubic | PAXgene | 0 | 6 pieces, no dermal fat; squamous epithelium is ~30-35 microns | Acceptable | |
| GTEX-1HBPN | 51-60 | Male | GTEX-1HBPN-0226 | Skin, leg | PAXgene | 0 | 6 pieces, no significant dermal fat; squamous epithelium is ~35 microns | Acceptable | |
| GTEX-1HBPN | 51-60 | Male | GTEX-1HBPN-0326 | Nerve - tibial | PAXgene | 0 | 2 pieces, trace adherent fat | Acceptable | |
| GTEX-1HBPN | 51-60 | Male | GTEX-1HBPN-0426 | Artery - tibial | PAXgene | 0 | 2 pieces, no adherent fat; trace atherosis | Acceptable | |
| GTEX-1HBPN | 51-60 | Male | GTEX-1HBPN-0526 | Muscle, skeletal | PAXgene | 0 | 2 pieces; ~10% interstitial fat/vascular elements | Acceptable | |
| GTEX-1HBPN | 51-60 | Male | GTEX-1HBPN-0626 | Coronary artery | PAXgene | 0 | 2 pieces, minute ((<1mm) probable branch (delineated). Excessive contaminating adherent fat. | Unacceptable | |
| GTEX-1HBPN | 51-60 | Male | GTEX-1HBPN-0726 | Adipose tissue | PAXgene | 0 | 2 pieces; ~20% fascia; rep delineated. | Acceptable | |
| GTEX-1HBPN | 51-60 | Male | GTEX-1HBPN-0826 | Heart | PAXgene | 1 | 2 pieces, diffuse lymphoid infiltrate with myocyte destruction c/w myocarditis. Reviewed by NIH consult panel | Unacceptable | |